Faculty Opinions recommendation of Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.

Cell Transplant ◽

Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma

Indian Journal of Hematology and Blood Transfusion ◽

10.1007/s12288-021-01490-1 ◽

2021 ◽

Author(s):

Jaikumar Patel ◽

Akanksha Garg ◽

Kinnari Patel ◽

Kamlesh Shah ◽

Sanket Shah ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Role of Salvage Radiation Therapy for Patients With Relapsed or Refractory Hodgkin Lymphoma Who Failed Autologous Stem Cell Transplant

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.04.007 ◽

2012 ◽

Vol 84 (3) ◽

pp. e329-e335 ◽

Cited By ~ 21

Author(s):

Jayant S. Goda ◽

Christine Massey ◽

John Kuruvilla ◽

Mary K. Gospodarowicz ◽

Woodrow Wells ◽

...

Keyword(s):

Radiation Therapy ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Salvage Radiation Therapy ◽

Biomarker analysis of pivotal phase II study of oral panobinostat (PAN) in relapsed/refractory Hodgkin lymphoma (HL) patients following autologous stem cell transplant (ASCT).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8046 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8046-8046 ◽

Cited By ~ 2

Author(s):

S. J. Harrison ◽

A. K. Hsu ◽

P. J. Neeson ◽

A. Younes ◽

A. Sureda ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Phase Ii ◽

Stem Cell Transplant ◽

Phase Ii Study ◽

Cell Transplant ◽

Pivotal Phase ◽

Biomarker Analysis ◽

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Leukemia & Lymphoma ◽

10.3109/10428194.2013.820287 ◽

2013 ◽

Vol 55 (5) ◽

pp. 1053-1060 ◽

Cited By ~ 8

Author(s):

Simon J. Harrison ◽

Andy K. Hsu ◽

Paul Neeson ◽

Anas Younes ◽

Anna Sureda ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study

European Journal Of Haematology ◽

10.1111/ejh.12973 ◽

2017 ◽

Vol 99 (6) ◽

pp. 553-558 ◽

Cited By ~ 7

Author(s):

Paul J. Bröckelmann ◽

Erin A. Zagadailov ◽

Shelby L. Corman ◽

Viktor Chirikov ◽

Courtney Johnson ◽

...

Keyword(s):

United Kingdom ◽

Stem Cell ◽

Retrospective Study ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Brentuximab Vedotin ◽

Cell Transplant ◽

Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1048208 ◽

2015 ◽

Vol 31 (7) ◽

pp. 1377-1389 ◽

Cited By ~ 6

Author(s):

Vijayveer Bonthapally ◽

Hongbo Yang ◽

Rajeev Ayyagari ◽

Ruo-Ding Tan ◽

Sean Cai ◽

...

Keyword(s):

Overall Survival ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Median Overall Survival ◽

Stem Cell Transplant ◽

Meta Analysis ◽

Brentuximab Vedotin ◽

Cell Transplant ◽

Consolidative Radiation Therapy Following Autologous Stem Cell Transplant in Relapsed or Refractory Hodgkin Lymphoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.173 ◽

2020 ◽

Vol 108 (3) ◽

pp. e752

Author(s):

M. Frick ◽

S.M. Hiniker ◽

C. Yoo ◽

R.T. Hoppe

Keyword(s):

Radiation Therapy ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland

Journal of Medical Economics ◽

10.1080/13696998.2016.1219358 ◽

2016 ◽

Vol 20 (1) ◽

pp. 8-18 ◽

Cited By ~ 3

Author(s):

Christopher Parker ◽

Beth Woods ◽

James Eaton ◽

Esprit Ma ◽

Ross Selby ◽

...

Keyword(s):

Stem Cell ◽

Cost Effectiveness ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Brentuximab Vedotin ◽

Cost Effectiveness Analysis ◽

Cell Transplant ◽

Effectiveness Analysis ◽

Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres

British Journal of Haematology ◽

10.1111/j.1365-2141.2011.08616.x ◽

2011 ◽

Vol 153 (3) ◽

pp. 358-363 ◽

Cited By ~ 27

Author(s):

Stephen D. Smith ◽

Craig H. Moskowitz ◽

Robert Dean ◽

Brad Pohlman ◽

Ronald Sobecks ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Faculty of 1000 evaluation for Early TARC reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718026606.793482985 ◽

2013 ◽

Author(s):

Anskar Leung

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽